Iatrogenic Alzheimer Disease? Amyloid-β Protein Transmission Between Humans
نویسندگان
چکیده
منابع مشابه
Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease.
Progressive cerebral deposition of the amyloid β-protein (Aβ) in brain regions serving memory and cognition is an invariant and defining feature of Alzheimer disease. A highly similar but less robust process accompanies brain aging in many nondemented humans, lower primates, and some other mammals. The discovery of Aβ as the subunit of the amyloid fibrils in meningocerebral blood vessels and pa...
متن کاملP135: The Role of Amyloid Beta-Peptides and Tau Protein in Alzheimer\'s Disease
Alzheimer's desease is the most common age-related neurodegenerative disorder, and cognitive problems such as defects in learning and memory are of its symptoms. Among the factors involved in the pathogenesis of the disease are biochemical disorders in protein production, oxidative stress, decreased acetylcholine secretion and inflammation of the brain tissue. Extra-neuronal accumulation ...
متن کاملStabilization of neurotoxic Alzheimer amyloid-β oligomers by protein engineering
Institute of Biomedicine, University of Gothenburg, SE-405 30 Gothenburg, Sweden; Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, United Kingdom; Department of Public Health and Caring Sciences/Geriatrics, Uppsala University, SE-751 25 Uppsala, Sweden; and Department of Molecular Biology, Swedish University of Agricultural Sciences (SLU), Uppsala Biomedical Center, SE-751 2...
متن کاملSpecific Inhibition of β-Secretase Processing of the Alzheimer Disease Amyloid Precursor Protein.
Development of disease-modifying therapeutics is urgently needed for treating Alzheimer disease (AD). AD is characterized by toxic β-amyloid (Aβ) peptides produced by β- and γ-secretase-mediated cleavage of the amyloid precursor protein (APP). β-secretase inhibitors reduce Aβ levels, but mechanism-based side effects arise because they also inhibit β-cleavage of non-amyloid substrates like Neure...
متن کاملMetal Chelator Decreases Alzheimer β-Amyloid Plaques
five CQ-treated mice, and two showed no measurable Alzheimer -Amyloid Plaques A in the pellet fraction and no detectable A pathology by immunocytochemistry. The authors then examined the effects of a higher dose (30 mg/kg/d) for 9 weeks in older 21-month-old mice (n ϭ 20) as compared to Transgenic mice developing -amyloid (A) plaques sham-fed mice (n ϭ 19). This resulted in a 41% decrease ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Neurosurgery
سال: 2016
ISSN: 0148-396X
DOI: 10.1227/01.neu.0000484057.12676.e3